Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Raoul Pieter Joost Koning"'
Autor:
Nicolas Van der Linden, Raoul Pieter Joost Koning, Daan van der Gouwe, Mireia Ventura, Fiona Measham
Publikováno v:
Drugs, Habits and Social Policy. 23:289-302
Purpose The purpose of this paper is to present some of the continued resistance and challenges faced by drug checking services (DCS) and review how the existing literature and the contributions to the special issue address them, with a view to makin
Autor:
Ruben Quirinus Vrolijk, Fiona Measham, Adrià Quesada, Anton Luf, Dominique Schori, Sarah Radley, Dean Acreman, Josie Smith, Marko Verdenik, Daniel Martins, Mar Cunha, Carlos J. Paulos, Ilaria Fineschi Piccinin, Enrico Gerace, Alexandra Karden, Raoul Pieter Joost Koning, Laura Alexandra Smit-Rigter, Mireia Ventura
Publikováno v:
Drugs, Habits and Social Policy. 23:207-219
Purpose The 3,4-methylenedioxymetamphetamine (MDMA) content in ecstasy tablets has increased enormously throughout Europe across the past decade. This study aims to determine whether this is caused by the production of “stronger” tablets (more mg
Autor:
Raoul Pieter Joost Koning, Nicolas Van der Linden, Daan van der Gouwe, Mireia Ventura, Fiona Measham
Publikováno v:
Drugs, Habits and Social Policy. 23:173-175
Publikováno v:
International Journal of Drug Policy, 105:103684, 1-2. Elsevier
Autor:
Jan van Amsterdam, Cees Maris, Raoul Pieter Joost Koning, Johannes G. Ramaekers, Gjalt-Jorn Peters, Ton Nabben, E.J.M. Pennings, Kaj Hollemans, Wim van den Brink, Floor van Bakkum, J J Breeksema, Tjibbe Reitsma, Tom Blickman, Willem Scholten, Judith Noijen
Publikováno v:
Amsterdam, J V, Peters, G-J Y, Pennings, E, Blickman, T, Hollemans, K, Breeksema, J J J, Ramaekers, J G, Maris, C, Bakkum, F V, Nabben, T, Scholten, W, Reitsma, T, Noijen, J, Koning, R & Brink, W V D 2021, ' Developing a new national MDMA policy : Results of a multi-decision multi-criterion decision analysis ', Journal of Psychopharmacology, vol. 35, no. 5, 0269881120981380, pp. 537-546 . https://doi.org/10.1177/0269881120981380
Journal of Psychopharmacology, 35(5):0269881120981380, 537-546. SAGE Publications Ltd
Journal of Psychopharmacology, 35(5), 537-546. SAGE Publications Inc.
Journal of psychopharmacology (Oxford, England), 35(5), 537-546. SAGE Publications Ltd
Journal of Psychopharmacology (Oxford, England)
Journal of Psychopharmacology, 35(5), 537-546. SAGE Publications Ltd
Journal of Psychopharmacology, 35(5):0269881120981380, 537-546. SAGE Publications Ltd
Journal of Psychopharmacology, 35(5), 537-546. SAGE Publications Inc.
Journal of psychopharmacology (Oxford, England), 35(5), 537-546. SAGE Publications Ltd
Journal of Psychopharmacology (Oxford, England)
Journal of Psychopharmacology, 35(5), 537-546. SAGE Publications Ltd
Background: Ecstasy (3,4-methylenedioxymethamphetamine (MDMA)) has a relatively low harm and low dependence liability but is scheduled on List I of the Dutch Opium Act (‘hard drugs’). Concerns surrounding increasing MDMA-related criminality coupl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76cf60f794eb5e34ad60b2743bb588d9
https://research.ou.nl/en/publications/5f18fe67-c218-4525-91f0-ee464bc8c268
https://research.ou.nl/en/publications/5f18fe67-c218-4525-91f0-ee464bc8c268
Publikováno v:
International Journal of Drug Policy, 95:103293, 1-5. Elsevier
Background: Drug checking services (DCS) provide information about drug content and purity, alongside personalized feedback, to people who use drugs; however, the demographic and drug use characteristics of DCS clients are rarely reported. This paper